News
Ovid Therapeutics and Takeda have agreed a deal worth up to $856 million, allowing the latter to take over development and commercialisation of the...
Beyond Batten Disease Foundation (BBDF) has partnered with Actelion Pharmaceuticals, a Janssen company, to provide Zavesca (miglustat) for the...
Bharat Biotech’s COVID-19 vaccine candidate has shown an interim efficacy of 81% in a Phase III trial, the company announced yesterday.
Researchers at Hong Kong Baptist University have developed a novel drug with the potential to become a next-generation treatment for cancers...
ConserV Bioscience and eTheRNA immunotherapies have agreed to collaborate on the development of vaccine candidates for infectious diseases.
The past week has continued to see positive COVID-19 news; COVAX has delivered their first batch of vaccines to Africa, CN Bio has received a...
Clinical stage medicine company ViaCyte have extended their collaboration with materials science organisation Gore to develop new candidates for the...
AbbVie has landed an option to buy neurodegenerative disease-focused biotech Mitokinin following completion of investigational new drug (IND)-...
NHS England has updated the Blueteq requirements for patients with highly active relapsing MS starting Merck’s cladribine (Mavenclad) tablets...
A US district court has ruled in favour of AstraZeneca in litigation against Mylan Pharmaceuticals and Kindeva Drug Delivery, AstraZeneca announced...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
